Ticker

Analyst Price Targets — CAI

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
February 17, 2026 10:04 amRobert W. Baird$26.00$20.62TheFly Caris Life Sciences initiated with an Outperform at Baird
January 5, 2026 2:46 pmEvercore ISI$38.00$26.68TheFly Caris Life Sciences price target lowered to $38 from $40 at Evercore ISI
December 22, 2025 11:52 amKyle MiksonCanaccord Genuity$30.00$27.94TheFly Caris Life Sciences price target raised to $30 from $28 at Canaccord
December 2, 2025 10:09 amCanaccord Genuity$28.00$26.05TheFly Caris Life Sciences initiated with a Hold at Canaccord
August 13, 2025 11:31 amMark MassaroBTIG$45.00$34.78TheFly Caris Life Sciences price target raised to $45 from $38 at BTIG
July 13, 2025 3:03 pmSubbu NambiGuggenheim$32.00$26.51TheFly Caris Life Sciences initiated with a Buy at Guggenheim

Latest News for CAI

BTSG vs. CAI: Which Stock Is the Better Value Option?

Investors with an interest in Medical Services stocks have likely encountered both BrightSpring Health Services, Inc. (BTSG) and Caris Life Sciences,?Inc. (CAI). But which of these two stocks presents investors with the better value opportunity right now?

Zacks Investment Research • Mar 3, 2026
Caris Life Sciences (NASDAQ:CAI) Shares Gap Up After Better-Than-Expected Earnings

Caris Life Sciences, Inc. (NASDAQ: CAI - Get Free Report) gapped up prior to trading on Friday following a better than expected earnings announcement. The stock had previously closed at $19.24, but opened at $21.16. Caris Life Sciences shares last traded at $21.32, with a volume of 1,119,366 shares. The company reported $0.28 EPS for the

Defense World • Feb 28, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for CAI.

No House trades found for CAI.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top